Reply to Reconsidering Dopaminergic Modulation in Alzheimer's Disease: A Case for Levodopa/Carbidopa as a Disease-Modifying Agent

AuthID
P-019-NAH
4
Author(s)
Damásio, J
·
Macedo-Ribeiro, S
·
Tipo de Documento
Letter
Year published
2025
Publicado
in ALZHEIMERS & DEMENTIA, ISSN: 1552-5260
Volume: 21, Número: 7
Indexing
Publication Identifiers
Pubmed: 40696846
SCOPUS: 2-s2.0-105011601063
Wos: WOS:001547240900001
Source Identifiers
ISSN: 1552-5260
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.